Finally, the specificity of tau-PET for the 3 R + 4 R tau that characterizes AD allows for the estimation of AD severity specifically, in contrast to cognitive decline, which is often the result of multiple comorbidities27. This evidence concerns the gene MAPT and Alzheimer disease.